NIH to Launch Human Safety Study of Ebola Vaccine Candidate

News   Aug 28, 2014

 
NIH to Launch Human Safety Study of Ebola Vaccine Candidate
 
 
 
 

RELATED ARTICLES

Ingestible Drug-Delivery Materials May Improve Patient Treatment Compliance

News

Hydrogel-based capsules could expand and reside in the GI tract for days, slowly releasing medication.

READ MORE

Nanoparticle Delivery of Curcumin Induces Tumor Cell Death

News

Attaching curcumin, a component of the common spice turmeric, to nanoparticles can be used to target and destroy treatment-resistant neuroblastoma tumor cells

READ MORE

LifeArc Becomes Technology Transfer Partner to London School of Hygiene & Tropical Medicine

News

LifeArc, the medical research charity, has partnered with London School of Hygiene & Tropical Medicine to provide a range of services in technology transfers.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE